Fennec Pharmaceuticals (NASDAQ:FENC – Get Free Report) released its earnings results on Monday. The company reported ($0.07) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.04, MarketWatch Earnings reports. The firm had revenue of $6.52 million during the quarter, compared to the consensus estimate of $5.22 million. During the same […]
Fennec Pharmaceuticals (NASDAQ:FENC – Get Free Report) will issue its quarterly earnings data before the market opens on Thursday, August 3rd. Analysts expect the company to announce earnings of ($0.18) per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link. Fennec Pharmaceuticals (NASDAQ:FENC – […]
Fennec Pharmaceuticals Inc. (TSE:FRX – Get Free Report) shares passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of C$11.34 and traded as low as C$11.27. Fennec Pharmaceuticals shares last traded at C$11.27, with a volume of 100 shares trading hands. Fennec Pharmaceuticals Price […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) CFO Robert Andrade sold 10,000 shares of Fennec Pharmaceuticals stock in a transaction on Wednesday, June 28th. The shares were sold at an average price of $8.99, for a total transaction of $89,900.00. Following the completion of the transaction, the chief financial officer now owns 139,721 shares in […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Rating) was the recipient of a large increase in short interest in the month of May. As of May 31st, there was short interest totalling 1,720,000 shares, an increase of 17.0% from the May 15th total of 1,470,000 shares. Approximately 7.9% of the shares of the stock are sold […]